Guohui Song

697 total citations
28 papers, 468 citations indexed

About

Guohui Song is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Guohui Song has authored 28 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Guohui Song's work include Sarcoma Diagnosis and Treatment (10 papers), Cancer Immunotherapy and Biomarkers (5 papers) and CAR-T cell therapy research (4 papers). Guohui Song is often cited by papers focused on Sarcoma Diagnosis and Treatment (10 papers), Cancer Immunotherapy and Biomarkers (5 papers) and CAR-T cell therapy research (4 papers). Guohui Song collaborates with scholars based in China, Taiwan and Hong Kong. Guohui Song's co-authors include Qinglian Tang, Jinchang Lu, Huaiyuan Xu, Xiaojun Zhu, Chuangzhong Deng, Changye Zou, Jingnan Shen, Jin Wang, Hongmin Chen and Xianbiao Xie and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Biomaterials.

In The Last Decade

Guohui Song

24 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guohui Song China 11 246 149 133 105 93 28 468
Yongfeng Jia China 6 206 0.8× 155 1.0× 109 0.8× 49 0.5× 90 1.0× 14 376
Pei Wu China 10 217 0.9× 122 0.8× 178 1.3× 47 0.4× 100 1.1× 33 505
Junyi Hou China 13 265 1.1× 173 1.2× 138 1.0× 79 0.8× 127 1.4× 29 470
Fanming Kong China 12 226 0.9× 96 0.6× 180 1.4× 87 0.8× 113 1.2× 61 515
Shenglin Ma China 13 264 1.1× 145 1.0× 179 1.3× 140 1.3× 115 1.2× 33 579
Zhigang Ma China 12 229 0.9× 201 1.3× 127 1.0× 59 0.6× 99 1.1× 26 466
Gabriele Romano United States 11 261 1.1× 138 0.9× 196 1.5× 61 0.6× 49 0.5× 18 484
Shugang Yang China 11 223 0.9× 118 0.8× 143 1.1× 107 1.0× 84 0.9× 16 426
C-W Wu Taiwan 10 283 1.2× 159 1.1× 168 1.3× 135 1.3× 86 0.9× 10 595
Haibo Mou China 10 128 0.5× 71 0.5× 117 0.9× 63 0.6× 60 0.6× 29 362

Countries citing papers authored by Guohui Song

Since Specialization
Citations

This map shows the geographic impact of Guohui Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guohui Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guohui Song more than expected).

Fields of papers citing papers by Guohui Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guohui Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guohui Song. The network helps show where Guohui Song may publish in the future.

Co-authorship network of co-authors of Guohui Song

This figure shows the co-authorship network connecting the top 25 collaborators of Guohui Song. A scholar is included among the top collaborators of Guohui Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guohui Song. Guohui Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Tianqi, Qinglian Tang, Chuangzhong Deng, et al.. (2025). Targeting OxLDL-mediated CD36 + CAF reprogramming potentiates PD-1 immunotherapy in osteosarcoma. Molecular Cancer. 25(1). 14–14.
2.
Lu, Jinchang, Yang Shao, Hui Fang, et al.. (2025). The histone lysine methyltransferase NSD3 drives osteosarcomagenesis by inactivating ARID3A. Cancer Letters. 633. 218045–218045.
3.
Huang, Yufeng, Chuangzhong Deng, Anfei Huang, et al.. (2024). Mass Spectrometry–Based Proteomics Identifies Serpin B9 as a Key Protein in Promoting Bone Metastases in Lung Cancer. Molecular Cancer Research. 22(4). 402–414. 1 indexed citations
4.
Lin, Jiaming, Guohui Song, Anfei Huang, et al.. (2024). Design and validation of a novel 3D-printed glenohumeral fusion prosthesis for the reconstruction of proximal humerus bone defects: a biomechanical study. Frontiers in Bioengineering and Biotechnology. 12. 1428446–1428446. 1 indexed citations
5.
Huang, Yufeng, Qinglian Tang, Jinxin Hu, et al.. (2024). Development and validation of a novel immune-related prognostic model and the potential metastatic mechanism in synovial sarcoma. Frontiers in Immunology. 15. 1448464–1448464.
6.
Zhu, Xiaojun, Jiaming Lin, Guohui Song, et al.. (2024). 3D-printed modular prostheses for reconstruction of intercalary bone defects after joint-sparing limb salvage surgery for femoral diaphyseal tumours. Bone & Joint Open. 5(4). 317–323. 1 indexed citations
7.
Deng, Chuangzhong, Hongmin Chen, Xiaojun Zhu, et al.. (2024). Extracellular-vesicle-packaged S100A11 from osteosarcoma cells mediates lung premetastatic niche formation by recruiting gMDSCs. Cell Reports. 43(2). 113751–113751. 19 indexed citations
8.
Tang, Qinglian, Anqi Wang, Guohui Song, et al.. (2024). Retrospective analysis of the clinical outcomes of paraspinal soft-tissue sarcoma. The Spine Journal. 25(5). 1018–1026.
9.
Tang, Qinglian, Jinchang Lu, Xiaojun Zhu, et al.. (2023). The efficacy and safety of short-course neoadjuvant denosumab for en bloc spondylectomy in spinal giant cell tumor of bone: a preliminary report. European Spine Journal. 32(12). 4297–4305. 2 indexed citations
10.
Song, Guohui, Hongmin Chen, Huaiyuan Xu, et al.. (2023). Surgical outcomes and risk factors for surgical complications after en bloc resection following reconstruction with 3D-printed artificial vertebral body for thoracolumbar tumors. World Journal of Surgical Oncology. 21(1). 385–385. 10 indexed citations
11.
Song, Guohui, et al.. (2023). Total en bloc spondylectomy with resection and replacement of the aorta: A case report and review of the literature. Asian Journal of Surgery. 46(11). 4826–4828. 2 indexed citations
12.
Xu, Huaiyuan, Jinxin Hu, YiJiang Song, et al.. (2022). Retinoic Acid Metabolism-Related Enzyme Signature Identified Prognostic and Immune Characteristics in Sarcoma. Frontiers in Cell and Developmental Biology. 9. 780951–780951. 2 indexed citations
13.
Song, YiJiang, Chuangzhong Deng, Xiaojun Zhu, et al.. (2021). Gene Expression Classifier Reveals Prognostic Osteosarcoma Microenvironment Molecular Subtypes. Frontiers in Immunology. 12. 623762–623762. 19 indexed citations
14.
Deng, Chuangzhong, Jianchang Fu, Xiaojun Zhu, et al.. (2020). Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma. Cancer Science. 111(6). 1899–1909. 67 indexed citations
15.
Zhu, Xiaojun, Jinchang Lu, Huaiyuan Xu, et al.. (2020). A Comparative Study Between Minimally Invasive Spine Surgery and Traditional Open Surgery for Patients With Spinal Metastasis. Spine. 46(1). 62–68. 27 indexed citations
16.
Chen, Hongmin, YiJiang Song, Chuangzhong Deng, et al.. (2020). Comprehensive analysis of immune infiltration and gene expression for predicting survival in patients with sarcomas. Aging. 13(2). 2168–2183. 10 indexed citations
17.
18.
Lu, Jinchang, Guohui Song, Qinglian Tang, et al.. (2015). IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling. Journal of Clinical Investigation. 125(5). 1839–1856. 98 indexed citations
19.
Song, Guohui, Jin Wang, Huaiyuan Xu, et al.. (2014). [Role of SCUBE3 in promoting osteosarcoma cell growth and its association with prognosis].. PubMed. 34(5). 617–21. 7 indexed citations
20.
Song, Guohui, Changye Zou, Qinglian Tang, et al.. (2014). Dihydromyricetin Activates AMP-Activated Protein Kinase and P38MAPK Exerting Antitumor Potential in Osteosarcoma. Cancer Prevention Research. 7(9). 927–938. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026